Neureliv 50mg Tablet

✔️ How Neureliv 50 Works:

• Epalrestat, the active ingredient, is an aldose reductase inhibitor. It works by blocking the accumulation of sorbitol in cells, which is implicated in the development of diabetic nerve disease.

✔️ Side Effects of Neureliv 50

• Common Side Effects:
  • Nausea
  • Vomiting
  • Abnormal liver function (e.g., increased liver enzymes)
• Less common side effects may include rash, abdominal pain, and other mild gastrointestinal symptoms. Contact your doctor if any side effects persist or worsen.

✔️ Word of Advice: Neureliv 50

Regularly follow your prescribed treatment plan, which may include diet, exercise, and blood sugar management, to help control symptoms and prevent further damage from diabetic neuropathy.

✔️ Indications: Neureliv 50

Neureliv 50 is used to treat diabetic nerve pain (diabetic neuropathy) in individuals with poorly controlled diabetes, which can lead to nerve damage. It helps relieve symptoms like burning pain and numbness commonly associated with this condition.

✔️ Dosage & Administration: Neureliv 50

• Usual Adult Dose: 50 mg (1 tablet) taken three times daily, before meals.
• Dosage Adjustment: May be adjusted based on the patient's age and symptom severity, under the guidance of a healthcare professional.

✔️ Missed Dose: Neureliv 50

If you miss a dose, take it as soon as you remember. If it's close to your next dose, skip the missed one—do not double the dose.

✔️ Interaction

• No known significant drug interactions with Neureliv have been documented.

✔️ Contraindications:

Hypersensitivity to epalrestat or any of its components.

✔️ Pregnancy & Lactation

• Pregnancy: The safety of Neureliv during pregnancy has not been established. It should only be used if the expected benefits outweigh the potential risks.
• Lactation: Avoid breastfeeding during the use of Neureliv due to potential risks.

✔️ Precautions & Warnings:

• Patients with high glycohemoglobin levels even after dietary management and diabetes treatment should be carefully considered for Neureliv therapy.
• Not recommended for patients with irreversible organic changes in diabetic peripheral neuropathy.
• Do not take if you are allergic to any component of the medication.
• Urine Color: Urine may turn yellowish-brown or reddish due to components of the medicine, which is harmless.
• Patients should be closely monitored during the administration of Neureliv. If no improvement is seen after 12 weeks, consider alternative treatments.

✔️ Storage:

• Store below 30°C in a dry, light-protected place.
• Keep out of reach of children.